Evolent Health (NYSE:EVH) & Phreesia (NYSE:PHR) Financial Survey

Phreesia (NYSE:PHR – Get Free Report) and Evolent Health (NYSE:EVH – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Phreesia and Evolent Health, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia 2 9 8 0 2.32
Evolent Health 1 3 10 0 2.64

Phreesia presently has a consensus price target of $13.87, suggesting a potential upside of 9.14%. Evolent Health has a consensus price target of $6.04, suggesting a potential upside of 23.61%. Given Evolent Health’s stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than Phreesia.

Insider & Institutional Ownership

92.1% of Phreesia shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Comparatively, 1.5% of Evolent Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Phreesia has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.

Valuation & Earnings

This table compares Phreesia and Evolent Health”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Phreesia $480.59 million 1.64 $2.31 million $0.17 74.74
Evolent Health $1.88 billion 0.29 -$534.51 million ($4.54) -1.08

Phreesia has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Phreesia and Evolent Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Phreesia 2.06% 5.22% 3.02%
Evolent Health -21.67% -6.07% -1.23%

Summary

Phreesia beats Evolent Health on 9 of the 14 factors compared between the two stocks.

About Phreesia

(Get Free Report)

Phreesia, Inc. provides software and services that help healthcare organizations manage interactions with patients. Its platform supports tasks such as patient registration and intake, appointment scheduling, payments, and communications before and after visits. Phreesia’s tools include digital and mobile options for completing forms and sharing information, as well as services designed to help providers engage patients and streamline administrative workflows. The company serves healthcare providers and organizations primarily in the United States.

About Evolent Health

(Get Free Report)

Evolent Health, Inc. provides technology-enabled services to health plans and healthcare providers in the United States. The company helps clients manage care, coordinate services and support the delivery of healthcare, particularly for people with complex medical needs. Its offerings include specialty care management programs, clinical and administrative services, and technology that supports care decisions and operations. Evolent has focused on areas such as oncology, cardiology, musculoskeletal care and behavioral health.

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.